SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Syschem (India) gains on receiving sales order of around Rs 1.20 crore

18 Aug 2023 Evaluate

Syschem (India) is currently trading at Rs. 48.12, up by 0.41 points or 0.86% from its previous closing of Rs. 47.71 on the BSE.

The scrip opened at Rs. 47.01 and has touched a high and low of Rs. 49.38 and Rs. 46.85 respectively. So far 52853 shares were traded on the counter.

The BSE group 'X' stock of face value Rs. 10 has touched a 52 week high of Rs. 65.10 on 23-Jan-2023 and a 52 week low of Rs. 35.15 on 19-Aug-2022.

Last one week high and low of the scrip stood at Rs. 49.85 and Rs. 45.05 respectively. The current market cap of the company is Rs. 153.07 crore.

The promoters holding in the company stood at 53.82%, while Non-Institutions held 46.18% stake in the company.

Syschem (India) has received sales order worth around Rs 1.20 crore only from Sunlovis Pharmaceuticals LLP towards Supply of Cephalexin Monohydrate (Compacted) BP; 1325 KGS and 1450 KG, 1AMOX02 Amoxicillin Trihydrate BP HSN/SAC. The said order is expected to be completed within 30 days.

Syschem (India) is a listed company engaged in the manufacture of Bulk Drugs/ Intermediates / Specialty Chemicals and contract manufacturing.


Syschem (India) Share Price

52.87 0.74 (1.42%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×